Importantly, signaling pathways activated by MIF and the pro-inflammatory cytokines, secreted after MIF binding to their receptors, have been shown to have important pro-tumorigenic effects in breast and other types of cancer [10,38]. The gene discussed is MIF; the disease is cancer.